戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 me dynamic effects of specific modulators of neutrophil chemotaxis.
2 further revealed an indirect effect of PT on neutrophil chemotaxis.
3 ectodomain was assessed in wound healing and neutrophil chemotaxis.
4 macrophage- and DC-mediated monocyte but not neutrophil chemotaxis.
5 cell migration and is involved in regulating neutrophil chemotaxis.
6 his in turn results in elevated monocyte and neutrophil chemotaxis.
7 umulation of leukocytes in the airspaces and neutrophil chemotaxis.
8 a lower secretion of cytokines and a lack of neutrophil chemotaxis.
9 actin synthesis and cell polarization during neutrophil chemotaxis.
10  Akt activity also inhibited fMLP-stimulated neutrophil chemotaxis.
11        The chemokine receptor CXCR2 mediates neutrophil chemotaxis.
12 important role in regulation of IL-8-induced neutrophil chemotaxis.
13 ningitis through inhibition of IL-8-mediated neutrophil chemotaxis.
14 onse to HRV-bacterial coinfection as well as neutrophil chemotaxis.
15  LPS-stimulated alveolar macrophages induced neutrophil chemotaxis.
16  does simple diffusion, which may facilitate neutrophil chemotaxis.
17  HLA-DR alleles was associated with impaired neutrophil chemotaxis.
18 th 875 microg/mL of surfactant did not alter neutrophil chemotaxis.
19 duced the ability of keratinocytes to induce neutrophil chemotaxis.
20 e and stroke led to reduced effectiveness of neutrophil chemotaxis.
21 s lipid peroxidation in S. aureus, promoting neutrophil chemotaxis.
22 d are crucial for directional sensing during neutrophil chemotaxis.
23  could be, in part, the result of defects in neutrophil chemotaxis.
24 lted in reduced CXCR2 expression and blocked neutrophil chemotaxis.
25 notype, which was confirmed by inhibition of neutrophil chemotaxis.
26 ion of pathogenic immune pathways, including neutrophil chemotaxis.
27  of proteins involved in IL-17 signaling and neutrophil chemotaxis.
28 ucidate the role of microenvironmental pH in neutrophil chemotaxis.
29 y were associated with pathways that control neutrophil chemotaxis.
30  drivers of the motile machinery involved in neutrophil chemotaxis.
31 here H(2)O(2) activates the SFK Lyn to drive neutrophil chemotaxis.
32 renines, which act through the AHR to impair neutrophil chemotaxis.
33 o degrade CXC chemokines, thereby preventing neutrophil chemotaxis.
34 ntial, and impaired cellular ATP release and neutrophil chemotaxis.
35 d cell differentiation, cell activation, and neutrophil chemotaxis.
36 eta-glucan-stimulated B lymphocytes elicited neutrophil chemotaxis.
37 rophil chemokine production but promotion of neutrophil chemotaxis.
38 tant of Cl66-Dox and Cl66-Pac cells enhanced neutrophil chemotaxis.
39 ablish domains for asthma diagnosis based on neutrophil chemotaxis.
40 nt AC9 activation and back retraction during neutrophil chemotaxis.
41 and mechanism of Rictor in the regulation of neutrophil chemotaxis.
42 ng assembly of the actin cytoskeleton during neutrophil chemotaxis.
43 receptors, causing significant impairment of neutrophil chemotaxis.
44 LR) activation motif and activates CXCR2 for neutrophil chemotaxis.
45 - and beta2-integrin activation and controls neutrophil chemotaxis.
46 ed Rac activation is necessary for efficient neutrophil chemotaxis.
47  fully automated, quantitative assessment of neutrophil chemotaxis.
48 t sacrificing the animal; and both 2D and 3D neutrophil chemotaxis.
49 ective for understanding the signals driving neutrophil chemotaxis.
50 ation experiment demonstrates MCP-1-mediated neutrophil chemotaxis.
51  of ARAP3 interferes with integrin-dependent neutrophil chemotaxis.
52 independently of actin reorganization during neutrophil chemotaxis.
53 in 1 and flotillin 2 in uropod formation and neutrophil chemotaxis.
54  neutrophil mobilization and MIP-2-dependent neutrophil chemotaxis.
55 d protein glycosylation (2 of 2), and normal neutrophil chemotaxis (1 of 1), and bactericidal activit
56 arget of rapamycin complex 2 (mTORC2) during neutrophil chemotaxis, a process that is mediated throug
57 ffects of anthrax lethal toxin (LT) on human neutrophil chemotaxis, a process that requires actin fil
58                In vitro, 14,15-DHET impaired neutrophil chemotaxis, acidification, CXCR1/CXCR2 expres
59 pha9beta1 and alpha4 integrins contribute to neutrophil chemotaxis across activated endothelial monol
60 th human leukocytes each n-3 DPA-SPM reduced neutrophil chemotaxis, adhesion and enhanced macrophage
61 (4), LXA(4) analogs, and ATL analogs inhibit neutrophil chemotaxis, adhesion to epithelium, and epith
62 .5% mucus, whereas 2.5% mucus best supported neutrophil chemotaxis against gravity.
63  potent in stimulating eosinophil as well as neutrophil chemotaxis, also capable of initiating actin
64 ng pH(e) below pH 6.8, predominantly affects neutrophil chemotaxis, although the velocity is largely
65             Likewise, patient plasma induced neutrophil chemotaxis, an effect decreased by reduction
66  It is established that H. pylori stimulates neutrophil chemotaxis and a robust respiratory burst, bu
67 ding of syndecan-1 is an underlying cause of neutrophil chemotaxis and aberrant wound healing that ma
68 tudy the mechanism by which mTORC2 regulates neutrophil chemotaxis and AC9 activity.
69 s on these cells will promote macrophage and neutrophil chemotaxis and activation and thereby play a
70 y of chemokines that play a critical role in neutrophil chemotaxis and activation both in vitro and i
71      Although the effects of leukotrienes on neutrophil chemotaxis and activation have been establish
72 e with this, the response was accompanied by neutrophil chemotaxis and activation of the superoxide-p
73                                Regulation of neutrophil chemotaxis and activation plays crucial roles
74 ne response to bacterial infections includes neutrophil chemotaxis and activation, but regulation of
75 own to contribute to monocyte/macrophage and neutrophil chemotaxis and activation.
76 cking N-formyl-Met-Leu-Phe- and IL-8-induced neutrophil chemotaxis and activation.
77 athogens must devise means to interfere with neutrophil chemotaxis and activation.
78 behavior and how the finely tuned balance of neutrophil chemotaxis and arrest counteracts bacterial e
79  by recurrent pyogenic infections, defective neutrophil chemotaxis and bactericidal activity, and lac
80  disorders, GPP, PPP, and AGEP, converged on neutrophil chemotaxis and diapedesis and cytokines known
81    Accordingly, calpain inhibition decreased neutrophil chemotaxis and directional persistence in a g
82 8 MAPK pathway responsible for regulation of neutrophil chemotaxis and exocytosis are unknown.
83     Our results suggest that Hsp27 regulates neutrophil chemotaxis and exocytosis in an actin-depende
84 he calcium-dependent protease calpain during neutrophil chemotaxis and found that calpain inhibition
85                                              Neutrophil chemotaxis and glucose metabolism were not si
86 Although DPPI(-/-) mice have normal in vitro neutrophil chemotaxis and in vivo neutrophil accumulatio
87       Here, we show that FGP phage stimulate neutrophil chemotaxis and induce a pertussis toxin-sensi
88                   We observed an increase in neutrophil chemotaxis and leukotriene B4 production and
89 nin receptor agonists inhibited IL-8-induced neutrophil chemotaxis and LPS-induced neutrophil recruit
90 ndings suggest that CXCR2 is responsible for neutrophil chemotaxis and margination induced by IL-8.
91 al, purinergic, and mTOR signaling regulates neutrophil chemotaxis and may be a pharmacological targe
92 iate an inflammatory cascade that can elicit neutrophil chemotaxis and neovascularization of the corn
93 n vivo effects of betaarr2 on CXCR2-mediated neutrophil chemotaxis and on cutaneous wound healing.
94 protein coupled receptor signaling, inhibits neutrophil chemotaxis and other inflammatory responses i
95 chemokine receptor-2 (CXCR2) ligand-mediated neutrophil chemotaxis and subsequent clearance of the in
96 kinase B) plays a central role in modulating neutrophil chemotaxis and superoxide generation in respo
97 ion and determine the specificity of Rac2 in neutrophil chemotaxis and superoxide generation.
98  isoform exhibit agonist-specific defects in neutrophil chemotaxis and superoxide production, despite
99 tion through p38 MAP kinase is necessary for neutrophil chemotaxis and that CRP intercedes through th
100 ntation of hyaluronan results in polymorphic neutrophil chemotaxis and that EC-SOD can completely pre
101                         Baclofen, stimulated neutrophil chemotaxis and tubulin reorganization in a PI
102  vivo studies suggest that PT and ACT affect neutrophil chemotaxis and/or function, thereby altering
103 toration of innate immune functions of blood neutrophils (chemotaxis and reactive oxygen species prod
104 al allografts induced epithelial activation, neutrophil chemotaxis, and a shift toward a Th17 adaptiv
105 mune response, chemokine-mediated signaling, neutrophil chemotaxis, and chemokine activity and distin
106 ade and tested for heparin binding, in vitro neutrophil chemotaxis, and in vivo neutrophil recruitmen
107 In vitro, thymosin beta4 sulfoxide inhibited neutrophil chemotaxis, and in vivo, the oxidized peptide
108     SLURP1 also suppressed the primary human neutrophil chemotaxis, and interaction with HUVEC.
109 he neuro-repellent, SLIT2, potently inhibits neutrophil chemotaxis, and might, therefore, be expected
110 e tetrazolium tests, myeloperoxidase assays, neutrophil chemotaxis, and neutrophil chemotaxis assays,
111 aureus has the potential to thwart effective neutrophil chemotaxis, and phagocytosis, and succeeds in
112 ntribute to chronic inflammation by inducing neutrophil chemotaxis, and the reduction of these microv
113 ell arrays; microenvironment fabrication for neutrophil chemotaxis; and complex, covert tags by the t
114  effects of E. coli capsule and O antigen on neutrophil chemotaxis are novel, and they expand our und
115  mechanisms that regulate 3-dimensional (3D) neutrophil chemotaxis are poorly understood.
116 n response to deltaPT infection, implicating neutrophil chemotaxis as a possible target of PT activit
117 he stimulated alveolar macrophages increased neutrophil chemotaxis as compared with unstimulated alve
118                In addition, the FMLP-induced neutrophil chemotaxis as well as superoxide generation w
119 emokines involved in monocyte/macrophage and neutrophil chemotaxis, as well as numerous receptors and
120 action (2 and 24 hours), ELISA (6 hours), or neutrophil chemotaxis assay (24 hours).
121               Second, we validated the mouse neutrophil chemotaxis assay by comparing the adhesion an
122 ity of the cell supernatants was tested by a neutrophil chemotaxis assay.
123                              Improvements in neutrophil chemotaxis assays have advanced our understan
124                                              Neutrophil chemotaxis assays were also used to evaluate
125 eroxidase assays, neutrophil chemotaxis, and neutrophil chemotaxis assays, revealed no identifiable a
126 e, and sample volume requirements to perform neutrophil chemotaxis assays.
127 )) from S. aureus were found to induce mouse neutrophil chemotaxis at 1-10 nM and superoxide producti
128 NHE1) with cariporide drastically attenuates neutrophil chemotaxis at the optimal pH(i) irrespective
129    Although SHIP1 has been shown to regulate neutrophil chemotaxis, B-cell signaling, and cortical os
130 ata suggest that NO does not directly affect neutrophil chemotaxis but may indirectly alter chemotact
131         Thus, spinorphin blocks fMLF-induced neutrophil chemotaxis by acting as a specific antagonist
132                                ScpB inhibits neutrophil chemotaxis by enzymatically cleaving the comp
133 esponse involves both a direct inhibition of neutrophil chemotaxis by estrogen and an altered express
134 mportant function of fever may be to enhance neutrophil chemotaxis by facilitating calcium influx thr
135 PDase1 plays an important role in regulating neutrophil chemotaxis by facilitating the hydrolysis of
136 These results suggest that PECAM-1 regulates neutrophil chemotaxis by modulating cell motility and di
137                Third, we show that 2D and 3D neutrophil chemotaxis can be directly compared using our
138  to chronic outcomes, and show that aberrant neutrophil chemotaxis can move an otherwise healthy outc
139                               Therefore, the neutrophil chemotaxis defect of IDDM appears to be indep
140 , growth factor activity, and eosinophil and neutrophil chemotaxis differing between subjects with se
141                   Mouse MCP-6 did not induce neutrophil chemotaxis directly in an in vitro assay, but
142 oepithelial layer; YbcL(UTI) did not inhibit neutrophil chemotaxis directly.
143  modulation of calpain activity may regulate neutrophil chemotaxis downstream of G-protein-coupled re
144            Molecules and pathways related to neutrophil chemotaxis emerged as common alterations in p
145   Rho GTPases control fundamental aspects of neutrophil chemotaxis: establishment of front and back a
146 , N-t-BOC-sensitive, and N-t-BOC-insensitive neutrophil chemotaxis ex vivo when cell-free bronchoalve
147 patients with OB was bioactive, we performed neutrophil chemotaxis experiments that showed that IL-8
148                                    Decreased neutrophil chemotaxis following exposure to rhAPC was co
149 ementation of neutrophils, and assessment of neutrophil chemotaxis following FL treatment.
150             Ad19 infection of HCFs increased neutrophil chemotaxis from a baseline of 0.4+/-0.7 cells
151     Neutralization of CXCL1 and IL-8 reduced neutrophil chemotaxis >50% to supernatants from IL-1beta
152                                    Depressed neutrophil chemotaxis has been demonstrated in IDDM and
153 cyl-phenylalanine (fMLP) and plays a role in neutrophil chemotaxis, has been implicated as a fluid sh
154             Blockade of interleukin-1, or of neutrophil chemotaxis, has reduced infarct volume in mod
155  bind to chemoattractants and play a role in neutrophil chemotaxis, have been implicated as fluid she
156        Vitamin D deficiency modestly impairs neutrophil chemotaxis; however, it does not affect lung
157  Discoidin domain receptor 2 (DDR2) promotes neutrophil chemotaxis in 3D by triggering matrix metallo
158 2D surfaces but is an important regulator of neutrophil chemotaxis in 3D collagen matrices.
159 lagen-derived extracellular signaling during neutrophil chemotaxis in 3D matrices.
160 (10 to 500 micrograms/ml) inhibited in vitro neutrophil chemotaxis in a concentration-dependent fashi
161 on of HLA-DR3, -DR4, and -DR53 with impaired neutrophil chemotaxis in an IDDM sample.
162                                  We describe neutrophil chemotaxis in response to a combination of a
163   Functionally, this was related to impaired neutrophil chemotaxis in response to CWF-conditioned med
164                                              Neutrophil chemotaxis in response to exogenous interleuk
165        This study brings new knowledge about neutrophil chemotaxis in the context of cell-to-cell com
166                                              Neutrophil chemotaxis in the direction of gravity was op
167 tic dorsal root ganglia suggested a role for neutrophil chemotaxis in the IPA-dependent regenerative
168              PAF mediates both apoptosis and neutrophil chemotaxis in the pancreas.
169 gly inhibits IL-8-induced and CXCR2-mediated neutrophil chemotaxis in vitro and alleviates hCXCR2-dep
170 dogenous anti-inflammatory agents that block neutrophil chemotaxis in vitro and inhibit neutrophil in
171                        Consistent with this, neutrophil chemotaxis in vitro and neutrophil mobilizati
172 e bioactivity of the parent NPD1, inhibiting neutrophil chemotaxis in vitro and neutrophil tissue inf
173 oncentrations of 2-chlorohexadecanal induced neutrophil chemotaxis in vitro suggesting that alpha-chl
174  We investigated the involvement of STIM1 in neutrophil chemotaxis in vitro, as well as during chroni
175 , N-t-BOC-sensitive, and N-t-BOC-insensitive neutrophil chemotaxis in vitro.
176 RP shown to inhibit C5a- and FMLP-stimulated neutrophil chemotaxis in vitro.
177       The mutants have a 10-fold decrease in neutrophil chemotaxis in vitro.
178 iously unknown mechanism of bacterial-guided neutrophil chemotaxis in vivo, providing insight into th
179 cally activates IL-8 and, thereby, regulates neutrophil chemotaxis in vivo.
180                                          The neutrophil chemotaxis index of 41 diabetics and 27 contr
181 B 225002 potently inhibited human and rabbit neutrophil chemotaxis induced by both IL-8 and GROalpha.
182              Spinorphin did not affect mouse neutrophil chemotaxis induced by concentrations of fMLF
183  chemotactic agonist and effectively blocked neutrophil chemotaxis induced by fMLF at concentrations
184                Recombinant IL-26 potentiated neutrophil chemotaxis induced by IL-8 and fMLP but decre
185                                 In addition, neutrophil chemotaxis induced by interleukin-8 was signi
186 d and exogenous syndecan-1 ectodomain induce neutrophil chemotaxis, inhibit alveolar epithelial wound
187                                              Neutrophil chemotaxis is a critical component of the inn
188                                    In vitro, neutrophil chemotaxis is affected in the mutant.
189 poxilin A3-driven transepithelial migration, neutrophil chemotaxis is amplified through neutrophil pr
190  of neutrophils, and in the absence of PDK1, neutrophil chemotaxis is impaired.
191 ther well-known eicosanoid mediating general neutrophil chemotaxis is leukotriene B4 (LTB4).
192  relevance of this TRPC6-depending defect in neutrophil chemotaxis is underscored by our in vivo find
193    CP-105,696 inhibited LTB4-mediated monkey neutrophil chemotaxis (isolated cells, LTB4 = 5 nM) and
194 howed that Rac2 is an essential regulator of neutrophil chemotaxis, L-selectin capture and rolling, a
195 trophils and is responsible for the abnormal neutrophil chemotaxis LAP.
196 r understanding of biochemical regulation of neutrophil chemotaxis, little is known about how mechani
197  understanding of the molecules that control neutrophil chemotaxis may impact our knowledge of autoim
198 nt mutations also allowed S. aureus to evade neutrophil chemotaxis, mediated by the reduction in bact
199 kt signaling in ICC cells, directly enhanced neutrophil chemotaxis, mediated tumor-associated neutrop
200 examined the involvement of CD38 in abnormal neutrophil chemotaxis of LAgP patients.
201                      As shown previously for neutrophils, chemotaxis of primary dermal fibroblasts to
202                                   First, the neutrophil chemotaxis on endothelial cells revealed 2 di
203 o-L-arginine) altered FMLP- or IL-8-elicited neutrophil chemotaxis (P > .25 for all).
204                AhR activation suppressed the neutrophil chemotaxis pathway involving Cxcl2, Cxcl3, an
205  In diabetic states, there is a reduction in neutrophil chemotaxis, phagocytosis, and reactive oxygen
206                                              Neutrophil chemotaxis plays an essential role in innate
207  These data suggest that PI3Kgamma regulates neutrophil chemotaxis primarily by controlling the direc
208 ed to affect primarily the directionality of neutrophil chemotaxis rather than motility, whereas knoc
209 ontribution of this GSK3-mediated pathway to neutrophil chemotaxis regulation depended on neutrophil
210                                              Neutrophil chemotaxis requires excitatory signals at the
211 and CXCL8 concentrations for mouse and human neutrophil chemotaxis, respectively.
212           Day 4 secondary endpoints included neutrophil chemotaxis, safety and tolerability, Sequenti
213                   In vitro human polymorphic neutrophil chemotaxis studies indicate that oxidative fr
214 t with 292 microg/mL significantly decreased neutrophil chemotaxis suggesting that at low concentrati
215 ynergy between intact SAA1alpha and CXCL8 in neutrophil chemotaxis, suggesting that this peptide bind
216  ability to recruit beta-arrestin and induce neutrophil chemotaxis, supporting the previous notion th
217 s mitochondrial protein biosynthesis, induce neutrophil chemotaxis, the generation of reactive oxygen
218  the CXC subfamily of chemokines, induces in neutrophils chemotaxis, the respiratory burst, granule r
219  macrophage polarization, and stimulation of neutrophil chemotaxis-these activities have been attribu
220 otaxis, but it also inhibited CXCL1-mediated neutrophil chemotaxis through CXCR2 antagonism.
221 rin and reversed fMLP's inhibitory effect on neutrophil chemotaxis through fibrin.
222 k-in neutrophils to fibrinogen and decreased neutrophil chemotaxis to a formyl-Met-Leu-Phe gradient.
223                          Thus, CD38 controls neutrophil chemotaxis to bacterial chemoattractants thro
224  was used to explore conditions that trigger neutrophil chemotaxis to Chlamydia trachomatis infected
225                 Finally, we demonstrate that neutrophil chemotaxis to fMLP is dependent on Ca++ mobil
226 al-relay molecule that exquisitely regulates neutrophil chemotaxis to formyl peptides, which are prod
227                     Similarly, C5a inhibited neutrophil chemotaxis to IL-8 and Gro-alpha.
228  use of morpholino oligonucleotides restores neutrophil chemotaxis to wounds.
229                                              Neutrophil chemotaxis toward C5a has an optimum at pH(i)
230 lusion, we propose that the pH dependence of neutrophil chemotaxis toward C5a is caused by a pH(i)-de
231 dentify Fer as a novel inhibitory kinase for neutrophil chemotaxis toward end target chemoattractants
232 -induced upregulation of proinflammatory and neutrophil chemotaxis transcripts and there was downregu
233                              The dynamics of neutrophil chemotaxis under competing chemoattractant gr
234                  Whereas dasatinib inhibited neutrophil chemotaxis under static conditions in 2 dimen
235                        This study identifies neutrophil chemotaxis velocity as a potential biomarker
236  proteins, we hypothesized that CRP inhibits neutrophil chemotaxis via inhibition of MAP kinase activ
237                   In addition, IL-17-induced neutrophil chemotaxis was dependent on CXCR2 signaling.
238                                      Ex vivo neutrophil chemotaxis was evaluated, using neutrophils f
239  reduced in Tph1(-/-) mice, whereas in vitro neutrophil chemotaxis was independent of serotonin.
240                                              Neutrophil chemotaxis was significantly suppressed by th
241                                    In vitro, neutrophil chemotaxis was stimulated by PTHrP 1-34.
242 he hemopoietic cell-restricted PI3K delta in neutrophil chemotaxis, we have developed a potent and se
243                     The random migration and neutrophil chemotaxis were significantly reduced.
244 thelial barrier function along with impaired neutrophil chemotaxis were the underlying mechanisms tha
245   Exudate levels of NO, a known inhibitor of neutrophil chemotaxis, were higher in F344, compared wit
246 of virulence genes and reduced hemolysis and neutrophil chemotaxis, while exhibiting increased surviv
247  each chemoattractant contributes to overall neutrophil chemotaxis within complex physiological envir
248 rophils under inflammatory conditions; mouse neutrophil chemotaxis without sacrificing the animal; an

 
Page Top